Furthermore, stratification of patients by ARID1A mutational status confirmed this relationship, where some ARID1A-mutated cancer subtypes (e.g., stomach adenocarcinoma—STAD) appear to upregulate KEAP1 compared to wild-type (Figure 3D and Supplementary Figure S3A). This evidence concerns the gene KEAP1 and cancer.